Pieter Busschaert

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Single-cell profiling in ovarian germ cell and sex cord-stromal tumours.

Single-cell profiling in ovarian germ cell and sex cord-stromal tumours.

Journal: British journal of cancer

Published: November 13, 2024

Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer.

Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: October 23, 2024

DAGIP: alleviating cell-free DNA sequencing biases with optimal transport.

DAGIP: alleviating cell-free DNA sequencing biases with optimal transport.

Journal: Genome biology

Published: November 24, 2023

PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.

PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 22, 2023

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.

Journal: Gynecologic oncology

Published: November 05, 2021

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer.

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer.

Journal: NPJ genomic medicine

Published: March 10, 2021

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.

Journal: Genome medicine

Published: May 06, 2020

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.

Journal: Cell research

Published: October 09, 2019

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.

Journal: Clinical epigenetics

Published: September 24, 2019

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 17, 2019

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.

Journal: Neoplasia (New York, N.Y.)

Published: February 04, 2019

Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis.

Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis.

Journal: Kidney international

Published: November 12, 2018

Showing 1-12 of 31

Last Updated: 09/26/2026